Parenteral Drugs (India) Limited — Others, 23-01-2025: Corporate Insolvency Resolution Process

The Hon’ble NCLT has approved the resolution plan for Parenteral Drugs (India) Ltd., submitted by IHL Lifesciences Private Limited. Under the plan, total claims of INR 1,17,93.09 lakh will see a recovery of approximately 4.91%, with a significant focus on operational creditors, receiving 100% of their claims. The infusion of new equity will also occur, enhancing capital structure.

This development marks a hopeful turn for the company, potentially stabilizing operations and renewing investor confidence amid previous insolvency challenges. Investors may view this as a positive outlook, with the business now poised for recovery and growth.